Source comparison
TB-500 Post-Surgery Recovery Mechanism: Dosing Protocol Comparison
Acute Healing (Days 3–14) 2–5mg Twice weekly 2–3 weeks Actin stabilization during peak fibroblast migration Primary protocol for fresh surgical wounds, optimal cell migration window Chronic Injury (Tendon/Ligament) 2–3mg Once weekly 4–8 weeks Sustained angioge
This comparison does not assign a generated winner or score.
- Acute Healing (Days 3–14)
- 2–5mg
- Twice weekly
- 2–3 weeks
- Actin stabilization during peak fibroblast migration
- Primary protocol for fresh surgical wounds, optimal cell migration window
- Chronic Injury (Tendon/Ligament)
- 2–3mg
- Once weekly
- 4–8 weeks
- Sustained angiogenesis in hypoxic tissue
- Used when blood flow limitation delays healing (e.g., rotator cuff, Achilles tendon)
- Maintenance (Post-Healing)
- 1–2mg
- 2–4 weeks
- Collagen remodeling support
- Applied after initial wound closure to improve scar quality and tensile strength
- High-Dose Loading
- 5–7mg
- Twice weekly for 1 week, then standard
- 3–4 weeks
- Rapid saturation of actin-binding sites
- Reserved for delayed healing cases or high-stress surgical sites
- Bottom Line
- Higher doses (5mg+) offer marginal gains beyond 2–3mg for most applications. Timing matters more than dose. Administering during the proliferation phase (days 3–14) is critical. Chronic injuries benefit from sustained lower doses rather than acute high-dose protocols.